{"organizations": [], "uuid": "4d221cf01ee8c39d88bdb30f72cb1a7aba95c84d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.prweb.com", "main_image": "http://ww1.prweb.com/prfiles/2013/02/19/12918335/2013 Ziegler CIA Logo_72dpi.jpg", "site_section": "http://www.prweb.com/rss2/finance.xml", "section_title": "Business: Finance", "url": "http://www.prweb.com/releases/2015/08/prweb12918335.htm", "country": "US", "title": "Ziegler Advises ContinuumRX, Inc. in Its Equity Financing", "performance_score": 0, "site": "prweb.com", "participants_count": 1, "title_full": "Ziegler Advises ContinuumRX, Inc. in Its Equity Financing", "spam_score": 0.0, "site_type": "news", "published": "2015-08-21T03:00:00.000+03:00", "replies_count": 0, "uuid": "4d221cf01ee8c39d88bdb30f72cb1a7aba95c84d"}, "author": "Leslie Weir", "url": "http://www.prweb.com/releases/2015/08/prweb12918335.htm", "ord_in_thread": 0, "title": "Ziegler Advises ContinuumRX, Inc. in Its Equity Financing", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Ziegler, a specialty investment bank, is pleased to announce its role in advising ContinuumRX, Inc. (ContinuumRX) on its $13.5 million round of new equity financing led by New Spring Capital. ContinuumRX is a home infusion company that operates joint ventures with six major health systems operating 25 hospitals. The unique service model helps hospitals gain efficiencies during the discharge process by providing patients with a seamless transition from the hospital to the home setting. The Company creates a single point of contact for physicians managing patients in the home and provides health plans, ACOs and payers with rich data regarding therapy compliance and avoidable readmissions.\nThe financing will enable expansion into new markets as well as expanding services within existing markets.\nChris Rogers , Managing Director in Ziegler's corporate finance healthcare practice, stated, \"The ContinuumRX management team has built a unique platform that provides an avenue for hospitals to improve their post-acute network outreach while improving patient care, reducing hospital readmissions and lowering the cost burden by placing patients in the appropriate infusion setting based on their needs. We are thrilled to have represented ContinuumRX in this transaction.\"\nZiegler’s Corporate Finance team is focused on delivering best-in-class advisory and financing solutions for companies and organizations across the healthcare industry. In our core practice areas of healthcare services, information technology, hospitals and senior living, Ziegler is one of the most active M&A firms offering innovative sell-side, buy-side, recapitalization/restructuring, equity private placement and strategic partnering services.\nFor more information about Ziegler, please visit us at http://www.Ziegler.com .\nAbout Ziegler:\nThe Ziegler Companies, Inc., together with its affiliates (Ziegler), is a privately held, specialty investment bank with unique expertise in complex credit structures and advisory services. Nationally, Ziegler is ranked as one of the leading investment banking firms in its specialty sectors of healthcare, senior living, religion, and education, as well as general municipal and structured finance. Headquartered in Chicago, IL with regional and branch offices throughout the U.S., Ziegler provides its clients with capital raising, corporate finance, FHA/HUD, strategic advisory services and research. Ziegler serves institutional and individual investors through its wealth management and capital markets distribution channels.\nCertain comments in this news release represent forward-looking statements made pursuant to the provisions of the Private Securities Litigation Reform Act of 1995. This client’s experience may not be representative of the experience of other clients, nor is it indicative of future performance or success. The forward-looking statements are subject to a number of risks and uncertainties, in particular, the overall financial health of the securities industry, the strength of the healthcare sector of the U.S. economy and the municipal securities marketplace, the ability of the Company to underwrite and distribute securities, the market value of mutual fund portfolios and separate account portfolios advised by the Company, the volume of sales by its retail brokers, the outcome of pending litigation, and the ability to attract and retain qualified employees.\n# # #", "external_links": ["http://www.prweb.net/Redirect.aspx?id=aHR0cDovL3d3dy56aWVnbGVyLmNvbS9pbnZlc3RtZW50LWJhbmtpbmcvY29ycG9yYXRlLWZpbmFuY2UvY2hyaXMtcm9nZXJzLw==", "http://www.prweb.net/Redirect.aspx?id=aHR0cDovL3d3dy5aaWVnbGVyLmNvbQ=="], "published": "2015-08-21T03:00:00.000+03:00", "crawled": "2015-08-22T00:07:39.947+03:00", "highlightTitle": ""}